Sartorius Aktiengesellschaft (XETRA:SRT3) — Market Cap & Net Worth
Market Cap & Net Worth: Sartorius Aktiengesellschaft (SRT3)
Sartorius Aktiengesellschaft (XETRA:SRT3) has a market capitalization of $8.87 Billion (€7.59 Billion) as of August 1, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #2420 globally and #496 in its home market, demonstrating a -1.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sartorius Aktiengesellschaft's stock price €218.00 by its total outstanding shares 34813621 (34.81 Million). See Sartorius Aktiengesellschaft capital spending ratio to understand how much of operating cash flow is reinvested back into capital assets.
Sartorius Aktiengesellschaft Market Cap History: 2015 to 2026
Sartorius Aktiengesellschaft's market capitalization history from 2015 to 2026. Data shows growth from $2.36 Billion to $8.87 Billion (14.88% CAGR).
Index Memberships
Sartorius Aktiengesellschaft is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
HDAX Performance
GDAXHI
|
$1.22 Trillion | 0.73% | #25 of 99 |
|
HDAX Price
GDAXHIP
|
$1.23 Trillion | 0.72% | #25 of 102 |
|
DAX Index
GDAXI
|
$1.03 Trillion | 0.86% | #20 of 40 |
|
DAX Price
GDAXIP
|
$1.03 Trillion | 0.86% | #20 of 40 |
Weight: Sartorius Aktiengesellschaft's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sartorius Aktiengesellschaft Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sartorius Aktiengesellschaft's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.84x
Sartorius Aktiengesellschaft's market cap is 2.84 times its annual revenue
Latest Price to Earnings (P/E) Ratio
64.95x
Sartorius Aktiengesellschaft's market cap is 64.95 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.79 Billion | $1.30 Billion | $102.93 Million | 2.14x | 27.07x |
| 2017 | $3.16 Billion | $1.40 Billion | $114.73 Million | 2.25x | 27.56x |
| 2018 | $4.35 Billion | $1.57 Billion | $141.34 Million | 2.78x | 30.77x |
| 2019 | $7.65 Billion | $1.83 Billion | $218.74 Million | 4.19x | 34.97x |
| 2020 | $13.84 Billion | $2.34 Billion | $321.47 Million | 5.92x | 43.05x |
| 2021 | $24.01 Billion | $3.45 Billion | $426.98 Million | 6.96x | 56.23x |
| 2022 | $14.95 Billion | $4.17 Billion | $913.10 Million | 3.58x | 16.37x |
| 2023 | $13.53 Billion | $3.40 Billion | $205.20 Million | 3.99x | 65.95x |
| 2024 | $8.76 Billion | $3.38 Billion | $84.00 Million | 2.59x | 104.27x |
| 2025 | $10.06 Billion | $3.54 Billion | $154.90 Million | 2.84x | 64.95x |
Competitor Companies of SRT3 by Market Capitalization
Companies near Sartorius Aktiengesellschaft in the global market cap rankings as of August 1, 2026.
Key companies related to Sartorius Aktiengesellschaft by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #187 globally with a market cap of $125.14 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #294 globally with a market cap of $88.81 Billion USD ( €75.96 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #343 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #529 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #187 | Intuitive Surgical Inc | NASDAQ:ISRG | $125.14 Billion | $353.33 |
| #294 | EssilorLuxottica S. A. | PA:EL | $88.81 Billion | €164.05 |
| #343 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €80.50 |
| #529 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Sartorius Aktiengesellschaft Historical Marketcap From 2015 to 2026
Between 2015 and today, Sartorius Aktiengesellschaft's market cap moved from $2.36 Billion to $ 8.87 Billion, with a yearly change of 14.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €8.87 Billion | -11.81% |
| 2025 | €10.06 Billion | +14.87% |
| 2024 | €8.76 Billion | -35.28% |
| 2023 | €13.53 Billion | -9.48% |
| 2022 | €14.95 Billion | -37.74% |
| 2021 | €24.01 Billion | +73.51% |
| 2020 | €13.84 Billion | +80.90% |
| 2019 | €7.65 Billion | +75.92% |
| 2018 | €4.35 Billion | +37.51% |
| 2017 | €3.16 Billion | +13.47% |
| 2016 | €2.79 Billion | +18.06% |
| 2015 | €2.36 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Sartorius Aktiengesellschaft was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.87 Billion USD |
| MoneyControl | $8.87 Billion USD |
| MarketWatch | $8.87 Billion USD |
| marketcap.company | $8.87 Billion USD |
| Reuters | $8.87 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more